Literature DB >> 15805560

Fibrinous peritonitis in a patient with rheumatoid arthritis.

R Kapoor1, E Dean, T Palferman, Z Khan.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15805560      PMCID: PMC1079443          DOI: 10.1177/014107680509800409

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  7 in total

1.  Letter: Delayed fibrinous peritonitis after practolol treatment.

Authors:  D Allan; D Cade
Journal:  Br Med J       Date:  1975-10-04

2.  Letter: beta-blockers and fibrinous peritonitis.

Authors:  J F Gurry; I G Cunningham; B N Brooke
Journal:  Br Med J       Date:  1975-05-31

3.  Letter: Beta-blockers and fibrinous peritonitis.

Authors:  R P Thompson; B T Jackson
Journal:  Br Med J       Date:  1975-06-28

4.  Fibrinous peritonitis: a complication of practolol therapy.

Authors:  W O Windsor; F Durrein; N H Dyer
Journal:  Br Med J       Date:  1975-04-12

5.  Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis.

Authors:  D O Clegg; D E Furst; K G Tolman; R Pogue
Journal:  J Rheumatol       Date:  1989-08       Impact factor: 4.666

6.  Rheumatoid constrictive pericarditis.

Authors:  E R McRorie; R A Wright; M L Errington; R A Luqmani
Journal:  Br J Rheumatol       Date:  1997-01

7.  Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate.

Authors:  G A Kujala; J M Shamma'a; W L Chang; J E Brick
Journal:  Arthritis Rheum       Date:  1990-07
  7 in total
  1 in total

Review 1.  Ascites and other incidental findings revealing undiagnosed systemic rheumatoid arthritis.

Authors:  Matthew Chak Hin Szeto; Benjamin Disney; Philip Perkins; Gordon Wood
Journal:  BMJ Case Rep       Date:  2015-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.